Preparation of hyaluronan oligosaccharides by a prokaryotic beta-glucuronidase: Characterization of free and immobilized forms of the enzyme.

Bacteroides fragilis Beta-glucuronidase Hyaluronan Immobilization Oligosaccharides

Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
01 Oct 2023
Historique:
received: 09 03 2023
revised: 26 05 2023
accepted: 29 05 2023
medline: 28 6 2023
pubmed: 27 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

Popularity of hyaluronan (HA) in the cosmetics and pharmaceutical industries, led to the investigation and development of new HA-based materials, with enzymes playing a key role. Beta-D-glucuronidases catalyze the hydrolysis of a beta-D-glucuronic acid residue from the non-reducing end of various substrates. However, lack of specificity towards HA for most beta-D-glucuronidases, in addition to the high cost and low purity of those active on HA, have prevented their widespread application. In this study, we investigated a recombinant beta-glucuronidase from Bacteroides fragilis (rBfGUS). We demonstrated the rBfGUS's activity on native, modified, and derivatized HA oligosaccharides (oHAs). Using chromogenic beta-glucuronidase substrate and oHAs, we characterized the enzyme's optimal conditions and kinetic parameters. Additionally, we evaluated rBfGUS's activity towards oHAs of various sizes and types. To increase reusability and ensure the preparation of enzyme-free oHA products, rBfGUS was immobilized on two types of magnetic macroporous bead cellulose particles. Both immobilized forms of rBfGUS demonstrated suitable operational and storage stabilities, and their activity parameters were comparable to the free form. Our findings suggest that native and derivatized oHAs can be prepared using this bacterial beta-glucuronidase, and a novel biocatalyst with enhanced operational parameters has been developed with a potential for industrial use.

Identifiants

pubmed: 37364952
pii: S0144-8617(23)00543-X
doi: 10.1016/j.carbpol.2023.121078
pii:
doi:

Substances chimiques

Glucuronidase EC 3.2.1.31
Hyaluronic Acid 9004-61-9
Enzymes, Immobilized 0
Oligosaccharides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121078

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgements The research was supported by projects of Charles University (SVV 260636 and Cooperatio 207032-3 Immunity and Infection)

Auteurs

Sofia Chatzigeorgiou (S)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic; Institute of Immunology and Microbiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

Jana Jílková (J)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic; Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. Electronic address: jilkova@contipro.com.

Lucie Korecká (L)

Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic. Electronic address: lucie.korecka@upce.cz.

Radka Janyšková (R)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic.

Martina Hermannová (M)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic.

Matej Šimek (M)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic.

Dagmar Čožíková (D)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic.

Marcela Slováková (M)

Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic.

Zuzana Bílková (Z)

Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic.

Jan Bobek (J)

Institute of Immunology and Microbiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Faculty of Science, Jan Evangelista Purkyně University in Ústí nad Labem, České mládeže 8, 400 96 Ústí nad Labem, Czech Republic; Faculty of Biomedical Engineering, Czech Technical University in Prague, Sítná sq. 3105, 272 01 Kladno, Czech Republic.

Zbyněk Černý (Z)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic.

Matouš Čihák (M)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic; Institute of Immunology and Microbiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

Vladimír Velebný (V)

Contipro a.s., Dolní Dobrouč 401, 56102 Dolní Dobrouč, Czech Republic.

Articles similaires

Humans Hyaluronic Acid Osteoarthritis, Hip Female Middle Aged
Substrate Specificity Peptides Catalysis Hydrolysis Protein Conformation
Lignin Biofuels Biomass Bacteria Fermentation

A clinical trial of ropivacaine in arthocentesis for TMD.

Laifeng Huang, Zeliu Huang, Shiyun Bi et al.
1.00
Humans Ropivacaine Temporomandibular Joint Disorders Anesthetics, Local Lidocaine

Classifications MeSH